Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 Deep, dose-dependent B cell depletion observed in peripheral blood and tissue Favorable safety profile with single target doses up to 30 µg as well as initial multi-dose regimen Data from the first […]
Category Archives: People
$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend well […]
Multi-Faceted Real Estate Business Celebrates Continued Success with the Opening of Its 66th Cash Home Buying Franchise in Sarasota, FL SARASOTA, Fla., June 05, 2026 (GLOBE NEWSWIRE) — New Again Houses®, a company that transforms old houses into fantastic modern homes, is thrilled to announce the opening of their 66th location in Sarasota, FL! The […]
Multi-Faceted Real Estate Business Celebrates Continued Success with the Opening of Its 65th Cash Home Buying Franchise in Pinellas County, FL ST. PETERSBURG, Fla., June 05, 2026 (GLOBE NEWSWIRE) — New Again Houses®, a company that transforms old houses into fantastic modern homes, is thrilled to announce the opening of their 65th location in Pinellas […]
Three-day public experience during New York Tech Week showcases the future of active work and recovery NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) — New York never stops. Yet despite the city’s constant motion, many professionals spend much of their workday sitting still. To challenge that reality, UREVO will debut a three-day Smart Wellness Pop-Up […]
Project will deliver 1.6 GW of reliable, low-emission, affordable baseload power with next-generation carbon capture technology MOUNT STORM, W.Va., June 05, 2026 (GLOBE NEWSWIRE) — TerraSpark today announced that the U.S. Department of Energy (DOE) has selected the TerraSpark Energy Campus to receive up to $18.5 million in federal funding to finance development of an […]
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes New data and real-world findings further emphasize pediatric safety, glycemic control and treatment satisfaction Exploratory analysis of inhaled insulin used with AID systems provides insight on the […]
Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and overweight Additional data from Phase 2 obesity clinical trial of ribupatide oral demonstrating mean weight loss of up to 12.1% with no observed plateau and up […]
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes • Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes […]
STAMFORD, Conn., June 05, 2026 (GLOBE NEWSWIRE) — Oban BioPharma today announced that preclinical data for OBT-676, a lead small-molecule candidate for the treatment of obesity and type 2 diabetes, has been selected for a late-breaking presentation at the upcoming American Diabetes Association (ADA) 86th Scientific Sessions being held from June 5th-8th in New Orleans, LA. […]


